Sirolimus — CAS 53123-88-9

Sirolimus (Rapamycin) is a macrolide immunosuppressant produced by Streptomyces hygroscopicus that inhibits the mechanistic target of rapamycin (mTOR). Used extensively in solid organ transplantation and for certain oncological indications. Mediocon Inc manufactures pharmaceutical-grade Sirolimus API at its GMP-certified Aurangabad facility.

• Organ transplant rejection prevention
• mTOR pathway inhibition
• Oncology (TSC, RCC)
• Immunosuppressant formulations

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support